Adiponectin and uses thereof
AssigneePhilera New Zealand Limited
InventorsGarth Cooper, Aimin Xu, Yu Wang
Life of this patent
Estimating the term…
Abstract
The invention provides methods and reagents for regulation of metabolic events, such as those mediated by adiponectin and adiponectin agonists. The invention also provides screening assays for identification of biologically active agents, diagnostic and therapeutic agents, and other methods and reagents.
Claims18
A composition which comprises a pharmaceutically acceptable carrier and substantially pure glycosylated human adiponectin in an amount effective for treating inflammation of the liver wherein the adiponectin comprises a glycosylated lysine residue at one or more positions of 65, 68, 77 and 101.
A composition which comprises a pharmaceutically acceptable carrier and substantially pure glycosylated human adiponectin in an amount effective for treating inflammation of the liver wherein the human adiponectin comprises a sugar moiety attached to one or more lysine residues at positions 65, 68, 77 and 101.
Dependencies are inferred from the claim text.